HoneyNaps, a Seoul, South Korea-based company which specializes in artificial intelligence (AI) sleep data analysis, raised $11.6M in funding.
Backers included Korea Industrial Bank, Hi investment Partners and QUAD Investment Management.
The company intends to use the funds to expand operations and its development efforts.
HoneyNaps is a “Sleep-Tech” company that won FDA approval for its AI-powered SOMNUM sleep diagnosis software in 2023, which is an algorithm that analyzes bio signal data during sleep and provides disease diagnoses under five minutes using its self-developed AI model. This AI diagnosis software is integrable into any medical and healthcare market using real-time large-scale bio signal.
Founded in July 2015, HoneyNaps has raised about $16.2M to date.
FinSMEs
27/05/2024